Cancer vaccine

This vaccine, known as BNT116 and developed by BioNTech, targets non-small cell lung cancer (NSCLC), the most common type of lung cancer. Its aim is to eliminate cancer cells and prevent their recurrence by training the immune system to recognize and attack these cancerous cells.

Personalized therapies effectively target tumors and dozens of clinical trials are underway in Greece

Millions of lives could be saved by a range of new vaccines for a range of diseases, including cancer, experts say. A leading pharmaceutical company has announced that by 2030 there will be vaccines against cancer, cardiovascular, autoimmune and other diseases, the Guardian writes.

Vaccines to fight cancer will be widely available before 2030, say husband and wife Prof. Ugur Şahin and Prof. Özlem Tureçi, creators of one of the most successful vaccines against COVID-19, writes in the New York Times.

Lessons learned from the pandemic will accelerate cancer treatments based on mRNA technology, they say.

The Turkish-German couple, who invented BioNTech, the first effective vaccine against COVID-19, with the U.S. giant Pfizer and saved millions of lives, has now succeeded in developing a vaccine that prevents pancreatic cancer from reforming.

A Cuban-developed cancer vaccine that is not licensed in any country other than Argentina is now being tested on 39 cancer patients in five different health centers in Turkey.

Although not a cure, the drug named Racotumomab has been shown in previous clinical trials conducted in Argentina and Cuba to extend survival about two to three months on average.